Catalya
PrivateLast Round
Seed
Jun 26, 2026
Total Funding Raised
$1.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Catalya is a biotechnology company that develops synthetic polymer platform technology to improve drug delivery and cell culture processes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Catalya Comparables
Compare Catalya with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InkVivo Technologies AG | 79% | |
| DelAQUA Pharmaceuticals, Inc. | 79% | |
| InnoCore Pharmaceuticals | 78% | |
Catalya Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 26, 2026 |
Catalya Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2026
Raised $1.7M from Noshaq and Fontem.
Catalya Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Catalya's valuation, stock price, and market status.